Frazier Life Sciences Management, L.P. Q2 2025 Filing
Filed August 14, 2025
Portfolio Value
$2.5T
Holdings
49
Report Date
Q2 2025
Filing Type
13F-HR
All Holdings (49 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | MIRMMIRUM PHARMACEUTICALS INC | 6,795,121 | $345.8B | 13.83% | |
| 2 | VRNAVERONA PHARMA PLC | 3,383,950 | $320.1B | 12.80% | |
| 3 | NAMSNEWAMSTERDAM PHARMA COMPANY | 16,607,074 | $300.8B | 12.03% | |
| 4 | BBIOBRIDGEBIO PHARMA INC | 3,800,457 | $164.1B | 6.56% | |
| 5 | ARQTARCUTIS BIOTHERAPEUTICS INC | 9,874,511 | $138.4B | 5.54% | |
| 6 | PHATPHATHOM PHARMACEUTICALS INC | 12,466,489 | $119.6B | 4.78% | |
| 7 | KRYSKRYSTAL BIOTECH INC | 688,460 | $94.6B | 3.78% | |
| 8 | IRONDISC MEDICINE INC | 1,654,834 | $87.6B | 3.50% | |
| 9 | MBXMBX BIOSCIENCES INC | 5,985,347 | $68.3B | 2.73% | |
| 10 | TARSTARSUS PHARMACEUTICALS INC | 1,397,527 | $56.6B | 2.26% | |
| 11 | TRVITREVI THERAPEUTICS INC | 10,259,409 | $56.1B | 2.24% | |
| 12 | MAZEMAZE THERAPEUTICS INC | 4,567,275 | $56.0B | 2.24% | |
| 13 | KALVKALVISTA PHARMACEUTICALS INC | 4,887,867 | $55.3B | 2.21% | |
| 14 | ZLABZAI LAB LTD | 1,308,138 | $45.7B | 1.83% | |
| 15 | AGIOAGIOS PHARMACEUTICALS INC | 1,279,754 | $42.6B | 1.70% | |
| 16 | RVMDREVOLUTION MEDICINES INC | 997,455 | $36.7B | 1.47% | |
| 17 | RAREULTRAGENYX PHARMACEUTICAL IN | 983,715 | $35.8B | 1.43% | |
| 18 | AURAAURA BIOSCIENCES INC | 5,100,000 | $31.9B | 1.28% | |
| 19 | ERASERASCA INC | 22,729,436 | $28.9B | 1.15% | |
| 20 | ALKSALKERMES PLC | 1,000,647 | $28.6B | 1.14% | |
| 21 | YB4PSAVARA INC | 11,462,301 | $26.1B | 1.05% | |
| 22 | MREOMEREO BIOPHARMA GROUP PLC | 9,440,112 | $25.6B | 1.02% | |
| 23 | ASNDASCENDIS PHARMA A/S | 133,333 | $23.0B | 0.92% | |
| 24 | EOLSEVOLUS INC | 2,435,550 | $22.4B | 0.90% | |
| 25 | HLVXHILLEVAX INC | 10,617,062 | $21.1B | 0.84% | |
| 26 | CGONCG ONCOLOGY INC | 770,000 | $20.0B | 0.80% | |
| 27 | AKROAKERO THERAPEUTICS INC | 366,784 | $19.6B | 0.78% | |
| 28 | CYTKCYTOKINETICS INC | 554,731 | $18.3B | 0.73% | |
| 29 | LXEOLEXEO THERAPEUTICS INC | 4,424,725 | $17.8B | 0.71% | |
| 30 | RNAAVIDITY BIOSCIENCES INC | 625,000 | $17.8B | 0.71% | |
| 31 | JBIOJADE BIOSCIENCES INC | 1,772,116 | $17.7B | 0.71% | |
| 32 | PVLAPALVELLA THERAPEUTICS INC NE | 722,400 | $16.3B | 0.65% | |
| 33 | PCVXVAXCYTE INC | 474,405 | $15.4B | 0.62% | |
| 34 | TVTXTRAVERE THERAPEUTICS INC | 1,002,092 | $14.8B | 0.59% | |
| 35 | DYNDYNE THERAPEUTICS INC | 1,505,984 | $14.3B | 0.57% | |
| 36 | COGTCOGENT BIOSCIENCES INC | 1,734,601 | $12.5B | 0.50% | |
| 37 | IMCRIMMUNOCORE HLDGS PLC | 384,782 | $12.1B | 0.48% | |
| 38 | ORICORIC PHARMACEUTICALS INC | 1,065,334 | $10.8B | 0.43% | |
| 39 | AUTLAUTOLUS THERAPEUTICS PLC | 4,623,324 | $10.5B | 0.42% | |
| 40 | VALNVALNEVA SE | 1,458,333 | $8.2B | 0.33% | |
| 41 | CBIOCRESCENT BIOPHARMA INC. | 453,685 | $7.3B | 0.29% | |
| 42 | DSGNDESIGN THERAPEUTICS INC | 1,953,547 | $6.6B | 0.26% | |
| 43 | ORKAORUKA THERAPEUTICS INC | 583,327 | $6.5B | 0.26% | |
| 44 | SLNSILENCE THERAPEUTICS PLC | 970,130 | $5.6B | 0.23% | |
| 45 | ALLOALLOGENE THERAPEUTICS INC | 3,868,750 | $4.4B | 0.17% | |
| 46 | NAMSNEWAMSTERDAM PHARMA COMPANY | 500,333 | $4.0B | 0.16% | |
| 47 | MGNXMACROGENICS INC | 3,175,665 | $3.8B | 0.15% | |
| 48 | AVU0ADVERUM BIOTECHNOLOGIES INC | 1,069,244 | $2.3B | 0.09% | |
| 49 | —ELEVATION ONCOLOGY INC | 5,993,579 | $2.2B | 0.09% |